Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,368 total articles
Blue Owl (OWL) has been through a painful reset as the private credit complex re-priced over the last year. With shares trading near the low end of the 52-week range, a high quarterly distribution, and free cash flow north of $1.28B, the market appears to have priced in worst-case outcomes. This trade idea targets a recovery back toward mid-cycle m…
Danone stepping back removes takeover premium uncertainty but does not undermine Lifeway's underlying business: consistent sales growth, clean balance sheet, and attractive operating returns. This is a mid-term swing trade that favors buying a measured pullback with a clear stop and a realistic upside target tied to the company’s history and near-t…
Arcutis is transitioning from pure R&D to a commercial growth story. ZORYVE posted $105.4M in Q1 2026 revenue (65% YoY) and management reaffirmed 2026 guidance of $480-495M. With pediatric label expansion, new formulations and a broader sales effort, the business is starting to compound. The setup favors a long trade with defined risk controls whil…
Keysight looks set to beat and raise on Q2 results thanks to sustained AI infrastructure demand, strong defense spending and healthy cash generation. The stock is extended but technicals and low short interest favor an orderly rally into an earnings-print trade. Proposed trade: enter at $360.00, stop $340.00, target $405.00 over the next 45 trading…
On Holding reported a solid Q1 with double-digit revenue growth, margin expansion, and a raised EBITDA guide. The shares trade well below their 52-week high, carry a $12.2B market cap, and show improving technicals. This trade idea outlines an actionable long with entry, stop, and target aimed at capturing a recovery toward renewed multiple expansi…
Pro-Dex (PDEX) looks like a fundamentally healthy small-cap: mid-teens P/E, strong ROE, positive free cash flow and low leverage. The stock has ripped above its 52-week high into thin liquidity, so the practical trade is to add on a measured pullback. Entry at $58.65, stop $52.00, target $70.00 for a mid-term (45 trading days) trade.
KLA trades like a mature tech bellwether at $1,892.80 with a market cap near $247B. Its inspection, metrology and process-control portfolio is critical to hyperscalers and foundries pushing toward 2nm nodes. Combine robust free cash flow ($4.01B), sky-high returns (ROE ~80%), and a 10-for-1 stock split announced for 06/11/2026, and you have a concr…
Qorvo has a credible operational rebound: improving cash flow, rising margins and diversified end markets. With market cap near $7.96B and free cash flow of $679.6M, the stock trades below recent highs yet above its 2025 low. Merger talk creates optionality but also uncertainty. This trade idea proposes a mid-term swing long to $106.30 with discipl…
Zeta Global (ZETA) posts healthy free cash flow and revenue growth, but a $4.1 billion market cap, EV/EBITDA ~36 and P/S near 2.9 price the stock for flawless execution. Recent regulatory noise, mixed insider/fund flows and technical weakness make the risk-reward skewed to the downside. This is a mid-term (45 trading days) short idea with a clearly…
Xometry's marketplace momentum, improving profitability and a tightened capital structure create a fertile setup. If a strategic partnership with Siemens materializes at scale, it would be transformative for distribution, digital shopfloor connectivity and top-line acceleration. This trade idea gives an actionable long entry with stop and target ac…
Intuitive Machines (LUNR) has become a poster child of the 2026 space rally. With near-term contract revenues, a 52-week range from $7.78 to $37.25, and strong market interest ahead of a SpaceX IPO, LUNR offers a tactical long trade. The setup is momentum-driven with clear catalysts, but the stock is expensive on sales and still unprofitable — this…
PROG Holdings (PRG) looks attractively valued after a string of earnings beats, meaningful free cash flow and an improving top-line mix. The stock trades at a single-digit P/E, an EV/EBITDA around 1.2 and a free cash flow yield north of 20%. We lay out a mid-term trade plan to capture a re-rating as the company converts earnings momentum into reven…
Allstate trades at roughly $216 with a mid-single-digit forward multiple, double-digit free cash flow and strong return on equity. Market concern over auto-loss deterioration appears priced into valuation. This trade is a mid-term swing: enter near $216.45, target $240, stop $201.
Grab trades near its 52-week low despite accelerating revenue and improving profitability. Recent headlines around Indonesian policy caps have pressured the stock and shorts have grown more active. We view the pullback as a tradeable long - entry at $3.60, stop at $3.20, and target at $5.50 - sized for a mid-term horizon while monitoring regulatory…
Lumen is pivoting from legacy consumer assets into AI-optimized fiber and Network-as-a-Service (NaaS) for enterprises. Recent enterprise customer wins, improving technical momentum, and a valuation that reflects execution risk create a defined long trade: buy for a 180-trading-day hold with a $15 target and an $8 stop.
Hemisphere Energy (HMENF) trades near $2.09 after a stretch of elevated short activity. With oil prices holding above recent levels, even modest cash-flow tailwinds could shift market expectations toward dividends or capital returns. This is a tactical, swing-oriented long idea sized for high-risk capital: entry $2.09, stop $1.65, target $3.50 — ho…
Snowflake's pullback has compressed downside and left valuation and technical indicators that favor a measured long. With positive cash flow, large enterprise deals showing up, and momentum indicators turning constructive, a mid-term trade to $200 offers a sensible risk-reward if you protect capital with a disciplined stop.
ORIX (IX) offers a pragmatic swing trade: enter around today's price to play upside from expected better-than-consensus results and constructive guidance. The company trades at a modest valuation (PE 14.3, PB 1.48) with a $41.7B market cap and improving technical momentum. Target and stop are defined to keep reward/risk favorable while acknowledgin…
Affirm is reporting GAAP profitability and meaningful free cash flow even as its shares trade at premium multiples (P/E ~80, P/S ~17.4). That combination explains investor enthusiasm, but it also makes the stock vulnerable to a re-rate if growth disappoints or credit costs tick up. We lay out a mid-term short trade with precise entry, stop and targ…
IBM's hybrid cloud and AI-infused infrastructure business is showing the kind of cash-flow improvement and margin leverage investors have been waiting for. At roughly $205B market cap and trading near $218, the stock still offers upside if execution continues; this trade idea lays out a concrete entry, stop and target for a long trade over the next…
Novo Nordisk's rebound is being driven by strong data and adoption for its oral Wegovy and next-gen obesity candidates. The pullback is over; fundamentals and valuation leave room for a measured long trade. Entry $46.00, stop $42.00, target $56.00 for a mid-term push tied to product uptake and continued data flow.
Roblox dropped sharply after management trimmed full-year bookings guidance in early May. That reset pushed the stock to near its 52-week low and left the business trading at equity-market prices that now reflect slower growth. With $1.5B of free cash flow, a $31.3B market cap and user traction still strong, this is a high-risk, high-reward long tr…
Constellation Energy is the U.S. nuclear backbone at the moment the market is scrambling for reliable, low-carbon megawatts to feed AI data centers. Q1 revenue and EPS beat, a completed Calpine acquisition, and explicit guidance put the company on a path to meaningful earnings growth. Given the enterprise value of roughly $105 billion, limited free…
Compass Pathways (CMPS) is trading near $10.70 with a market cap just above $1.0B after a regulatory shift and two positive Phase 3 readouts for COMP360. Technical momentum, falling short interest days-to-cover, and a compressed valuation versus potential revenue per patient support a long trade. We lay out an entry at $10.70, stop at $8.50 and a t…
Abaxx has cleared several execution questions after launching its physically-settled LNG and carbon futures and showing persistent share-price strength. That progression makes a controlled, swing-oriented long plausible, but the company's $1.54B market cap and thin fundamentals leave little margin for error. Trade with a defined stop and realistic …
